ACT Forum (@TheACTForum) header
ACT Forum (@TheACTForum) profile picture

🧡 Coming Soon: A scientific and educational platform focused on advancing understanding of emerging cell-based approaches to managing autoimmune diseases.

United Kingdom
Joined September 2026
Photo by ACT Forum (@TheACTForum)Photo by ACT Forum (@TheACTForum)Photo by ACT Forum (@TheACTForum)Photo by ACT Forum (@TheACTForum)Photo by ACT Forum (@TheACTForum)Photo by ACT Forum (@TheACTForum)Photo by ACT Forum (@TheACTForum)Photo by ACT Forum (@TheACTForum)
Thank you to everyone who visited us at #ACR26! 👋 It was great to give attendees a first look at the Autoimmune Cell Therapies Forum (ACT Forum) and share our plans for this exciting new educational resource. Ahead of our official launch in early 2027, we look forward to sharing more expert insights, emerging evidence, and educational opportunities. 🔗 Register your interest today to stay up to date with the latest CAR T-cell developments and news from ACT Forum: ow.ly/foNW5105IG8
1
1
52
Open the thread to take a look at some of the key #CART sessions from #ACR26 👇
8
56
🌟 Highlighted 🌟 4:00pm - 4:15pm 1902: CD19 CAR T-Cell Therapy in Highly Treatment-Refractory Rheumatoid Arthritis: Phase 1 Results from the COMPARE Trial David Simon, MD #ACR2026
7
🌟 Highlighted 🌟 10:30am - 12:30pm 0454: IL-6/TNFα-neutralizing CD19 CAR T-cell therapy in difficult-to-treat rheumatoid arthritis: Long-term follow-up and immune remodeling Zhu Chen, MD #ACR2026
9
1178: Preliminary Safety and Efficacy Results From a First-in-Human Phase 1 Clinical Study of ALLO-329, a Dual Anti-CD19/Anti-CD70 Allogeneic CAR T-Cell Therapy for Autoimmune Disease 👤Vivek Nagaraja ⏰10:30 AM - 12:30 PM
1
11
0223: Preliminary Safety and Efficacy of a CD19-Targeted In Vivo CAR-T Cell Therapy in Patients with Refractory Systemic Sclerosis 👤Pian Zhang ⏰10:30 AM - 12:30 PM
1
9
0225: Safety and Efficacy of Anti-CD19 Allogenic Chimeric Antigen Receptor (CAR) T Cell Therapy Zugocabtagene Geleucel (zugo-cel) in Patients with Refractory Systemic Sclerosis 👤 Lorinda Chung ⏰ 10:30 AM - 12:30 PM
1
10
2216: Obecabtagene autoleucel (obe-cel), a CD19-targeting Chimeric Antigen Receptor (CAR) T-cell Therapy, in Adults and Adolescents with Severe, Refractory Systemic Lupus Erythematosus (srSLE): Findings from the Phase I CARLYSLE Study 👤Claire Roddie ⏰10:30 AM - 12:30 PM
1
16
1216: Durable drug-free state, reduced infectious burden and a revamped B-cell environment several years after CD19-CAR-T cell therapy in SLE 👤 Laura Bucci ⏰10:30 AM - 12:30 PM
1
9
0280: Safety and Efficacy of AZD0120 (GC012F), a Dual-Targeting CD19/BCMA CAR-T Cell Therapy, in Refractory Systemic Lupus Erythematosus: Phase 1/2 Interim Results 👤 Qiong Fu ⏰10:30 AM - 12:30 PM
1
24
A first look at the future of autoimmune cell therapy education. 🔬 At #ACR26, we're offering a preview of ACT Forum before its official launch in the new year. Curious about what we're building? Come and explore the forum, meet the team and find out what's ahead. 📍 Stand 4619
1
2
102
Tomorrow, get your first look at ACT Forum! 👀 📍 Join us at ACR Convergence, Stand 4619, to preview our new educational forum ahead of its 2027 launch. 🔗 Register to stay up to date with emerging advances: ow.ly/S61I5103f4O
1
32
ACT Forum retweeted
🧬 Ahead of #ACR26, I’m delighted to share the launch of the Autoimmune Cell Therapies Forum (@TheACTForum) & honoured to be appointed its Chair 🚀 Our mission is simple: to make the rapidly evolving world of cell therapies more accessible 🔗 Register: celltherapy-forum.com
Meet the ACT Forum Steering Committee! 👋 Bringing together leading experts in autoimmune cell therapies to connect HCPs with emerging evidence, clinical trials and the latest advances in this rapidly evolving field. 🔗 ow.ly/7oUR5103f2B
1
6
23
817
3 days until your first look at ACT Forum! 📍 Find us at Stand 4619 at ACR Convergence in Orlando, FL. 🔗 Register your interest to stay up to date with emerging CAR T-cell evidence and advances: ow.ly/RX085103feh
25
Meet the ACT Forum Steering Committee! 👋 Bringing together leading experts in autoimmune cell therapies to connect HCPs with emerging evidence, clinical trials and the latest advances in this rapidly evolving field. 🔗 ow.ly/7oUR5103f2B
1
1
7
786
The ACT Forum team will be at the ACR Convergence! If you're attending, come and meet the team and discover what ACT Forum will offer. 📍 Visit us at Stand 4619! 🔗 Register your interest to stay connected with emerging data and developments: ow.ly/YApN5103eZU
3
42
Meet ACT Forum Chair, Dr Chris Wincup 👋 Hear how he'll help to shape the forum's resources and bring together expert perspectives from across the field. Stay up to date with the latest in cell therapies: celltherapy-forum.com/regist…
1
5
44
CAR T-cell therapy is rapidly evolving, with emerging data and clinical trials continuing to shape the field. ACT Forum will help clinicians stay informed, explore new evidence, and build on existing knowledge. Register today to stay up to date: celltherapy-forum.com/
4
22